HEALTHglobal
Embecta to buy auto-injector maker Owen Mumford for $200M to diversify beyond insulin - Fierce Biotech
Single source
Updated 3 hours ago
First seen March 20, 2026 11:11:10Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.
Quick Summary
Embecta to buy auto-injector maker Owen Mumford for $200M to diversify beyond insulin Fierce Biotech